Application 018925

Type
NDA
Sponsor
EXELA PHARMA SCS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VERAPAMIL HYDROCHLORIDEVERAPAMIL HYDROCHLORIDESOLUTION;INTRAVENOUS5MG/2ML (2.5MG/ML)NoNo
002VERAPAMIL HYDROCHLORIDEVERAPAMIL HYDROCHLORIDESOLUTION;INTRAVENOUS10MG/4ML (2.5MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51662-1442VERAPAMIL HCIVERAPAMIL HCIHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51662-1442VERAPAMIL HCIVERAPAMIL HCIHF Acquisition Co LLC, DBA HealthFirstNDACurrent
51754-0203Verapamil HydrochlorideVerapamil HydrochlorideEXELA PHARMA SCIENCES, LLCNDACurrent
51754-0203Verapamil HydrochlorideVerapamil HydrochlorideEXELA PHARMA SCIENCES, LLCNDACurrent
51754-0204Verapamil HydrochlorideVerapamil HydrochlorideEXELA PHARMA SCIENCES, LLCNDACurrent
51754-0205Verapamil HydrochlorideVerapamil HydrochlorideEXELA PHARMA SCIENCES, LLCNDACurrent
51754-0205Verapamil HydrochlorideVerapamil HydrochlorideEXELA PHARMA SCIENCES, LLCNDACurrent
71872-7048Verapamil HydrochlorideVerapamil HydrochlorideMedical Purchasing Solutions, LLCNDACurrent
71872-7048Verapamil HydrochlorideVerapamil HydrochlorideMedical Purchasing Solutions, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
45912SUPPL2016-11-22
45942SUPPL2016-11-21
1128SUPPL2011-11-07
11363SUPPL2011-11-04
33649SUPPL2010-04-19
16097SUPPL2010-04-19